These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19430404)

  • 1. Perception of burden experienced during diagnostic tests by melanoma patients with lymph node metastases.
    Bastiaannet E; Hoekstra-Weebers JE; Francken AB; Jager PL; van der Jagt EJ; Hoekstra HJ
    Melanoma Res; 2009 Feb; 19(1):36-41. PubMed ID: 19430404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Views of UK melanoma patients on routine follow-up care.
    Dancey A; Rayatt S; Courthold J; Roberts J
    Br J Plast Surg; 2005 Mar; 58(2):245-50. PubMed ID: 15710122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic melanoma cells in the sentinel node cannot be ignored.
    Ollila DW; Ashburn JH; Amos KD; Yeh JJ; Frank JS; Deal AM; Long P; Thomas ND; Meyers MO
    J Am Coll Surg; 2009 May; 208(5):924-9; discussion 929-30. PubMed ID: 19476863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychosocial burden and subjective experience of melanoma patients in the ambulant follow-up].
    Blum A; Blum D; Stroebel W; Rassner G; Garbe C; Hautzinger M
    Psychother Psychosom Med Psychol; 2003 Jun; 53(6):258-66. PubMed ID: 12813660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma].
    Avilés-Izquierdo JA; Lázaro-Ochaita P
    Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
    Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of the detection of metastases and follow-up examinations in cutaneous melanoma.
    Leiter U; Marghoob AA; Lasithiotakis K; Eigentler TK; Meier F; Meisner C; Garbe C
    Melanoma Res; 2009 Feb; 19(1):50-7. PubMed ID: 19430406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological status and coping with illness in patients with malignant melanoma.
    Vurnek M; Buljan M; Situm M
    Coll Antropol; 2007 Jan; 31 Suppl 1():53-6. PubMed ID: 17469751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient satisfaction with receiving skin cancer diagnosis by letter: comparison with face-to-face consultation.
    Karri V; Bragg TW; Jones A; Soldin M; Misch K
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):1059-62. PubMed ID: 18485851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
    J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous melanoma in the elderly.
    Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
    Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological status and illness perceptions in patients with melanoma.
    Vurnek Zivković M; Buljan M; Blajić I; Situm M
    Coll Antropol; 2008 Oct; 32 Suppl 2():75-8. PubMed ID: 19140271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' experience of the diagnosis and treatment of skin cancer.
    Winterbottom A; Harcourt D
    J Adv Nurs; 2004 Nov; 48(3):226-33. PubMed ID: 15488036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study.
    Holterhues C; Cornish D; van de Poll-Franse LV; Krekels G; Koedijk F; Kuijpers D; Coebergh JW; Nijsten T
    Arch Dermatol; 2011 Feb; 147(2):177-85. PubMed ID: 21339445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death.
    Chen LL; Nolan ME; Silverstein MJ; Mihm MC; Sober AJ; Tanabe KK; Smith BL; Younger J; Michaelson JS
    Cancer; 2009 Nov; 115(21):5071-83. PubMed ID: 19658184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.